NTRA insider transactions

SEC. AND CHIEF LEGAL OFFICER Rabinowitz Daniel sold $485,106 worth of shares (1,887 units at $257.08) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 170,407 units (SEC Form 4) (for tax liability)

EXECUTIVE CHAIRMAN Rabinowitz Matthew sold $447,523 worth of shares (1,718 units at $260.49) as part of a pre-agreed trading plan, decreasing direct ownership by 0.08% to 2,276,125 units (SEC Form 4) to satisfy withholding tax

CO-FOUNDER Sheena Jonathan sold $123,549 worth of shares (479 units at $257.93) as part of a pre-agreed trading plan, decreasing direct ownership by 0.19% to 245,723 units (SEC Form 4) to satisfy withholding tax

PRESIDENT, CLINICALDIAGNOSTICS Moshkevich Solomon sold $568,997 worth of shares (2,214 units at $257.00) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 132,429 units (SEC Form 4) (for tax liability)

PRESIDENT, CHIEF BUS. OFFICER Fesko John sold $440,243 worth of shares (1,713 units at $257.00) as part of a pre-agreed trading plan, decreasing direct ownership by 0.92% to 184,069 units (SEC Form 4) (for tax liability)

CEO AND PRESIDENT Chapman Steven Leonard sold $1,480,047 worth of shares (5,770 units at $256.51) as part of a pre-agreed trading plan, decreasing direct ownership by 5% to 102,973 units (SEC Form 4) (for withholding tax)

CHIEF FINANCIAL OFFICER Brophy Michael Burkes sold $1,282,634 worth of shares (5,064 units at $253.28) as part of a pre-agreed trading plan, decreasing direct ownership by 9% to 52,432 units (SEC Form 4) (tax withholding)

Director Chapman Rowan E sold $37,101 worth of shares (135 units at $274.82) as part of a pre-agreed trading plan, decreasing direct ownership by 3% to 4,663 units (SEC Form 4)

CO-FOUNDER Sheena Jonathan sold $410,825 worth of shares (1,500 units at $273.88) as part of a pre-agreed trading plan (SEC Form 4)

CO-FOUNDER Sheena Jonathan sold $836,898 worth of shares (3,150 units at $265.68) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 246,202 units (SEC Form 4)

EXECUTIVE CHAIRMAN Rabinowitz Matthew sold $280,000 worth of shares (1,000 units at $280.00) as part of a pre-agreed trading plan (SEC Form 4)

SEC. AND CHIEF LEGAL OFFICER Rabinowitz Daniel sold $4,574,431 worth of shares (16,800 units at $272.29) as part of a pre-agreed trading plan, decreasing direct ownership by 9% to 172,294 units (SEC Form 4)

PRESIDENT, CLINICALDIAGNOSTICS Moshkevich Solomon sold $818,710 worth of shares (3,000 units at $272.90) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 134,643 units (SEC Form 4)

Director Lynch Thomas J. Jr. was granted 1,905 shares (SEC Form 4)

Director Marcus Gail Boxer was granted 1,669 shares, increasing direct ownership by 27% to 7,852 units (SEC Form 4)

Director Botha Roelof was granted 1,691 shares, increasing direct ownership by 58% to 4,585 units (SEC Form 4)

Director Rosenman Herm was granted 1,677 shares, increasing direct ownership by 39% to 5,927 units (SEC Form 4)

Director Rubin Eric H was granted 75 shares, increasing direct ownership by 4% to 2,204 units (SEC Form 4)

Director Chapman Rowan E was granted 1,674 shares, increasing direct ownership by 54% to 4,798 units (SEC Form 4)

Director Baynes Roy D. was granted 1,646 shares, increasing direct ownership by 9% to 20,158 units (SEC Form 4)

Director Bertagnolli Monica was granted 1,646 shares, increasing direct ownership by 31% to 7,020 units (SEC Form 4)

SEC. AND CHIEF LEGAL OFFICER Rabinowitz Daniel sold $8,455,355 worth of shares (33,600 units at $251.65) as part of a pre-agreed trading plan, decreasing direct ownership by 15% to 189,094 units (SEC Form 4)

Director Rosenman Herm sold $4,132,500 worth of shares (16,530 units at $250.00) as part of a pre-agreed trading plan, decreasing direct ownership by 80% to 4,250 units (SEC Form 4)

CO-FOUNDER Sheena Jonathan sold $329,810 worth of shares (1,500 units at $219.87) as part of a pre-agreed trading plan (SEC Form 4)

Director Chapman Rowan E sold $642,536 worth of shares (2,964 units at $216.78) as part of a pre-agreed trading plan, decreasing direct ownership by 49% to 3,124 units (SEC Form 4)

CO-FOUNDER Sheena Jonathan sold $665,087 worth of shares (3,150 units at $211.14) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 249,352 units (SEC Form 4)

EXECUTIVE CHAIRMAN Rabinowitz Matthew sold $21,447,308 worth of shares (100,000 units at $214.47) as part of a pre-agreed trading plan, decreasing direct ownership by 4% to 2,277,843 units (SEC Form 4)

Director Marcus Gail Boxer sold $2,389,328 worth of shares (11,000 units at $217.21) and exercised 11,000 shares at a strike of $22.83 (SEC Form 4)

SEC Form 3 filed by new insider Lynch Thomas J. Jr.

CEO AND PRESIDENT Chapman Steven Leonard sold $9,089,776 worth of shares (41,124 units at $221.03) as part of a pre-agreed trading plan, decreasing direct ownership by 27% to 108,743 units (SEC Form 4)

PRESIDENT, CLINICALDIAGNOSTICS Moshkevich Solomon sold $655,295 worth of shares (3,000 units at $218.43) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 137,643 units (SEC Form 4)

Director Rubin Eric H was granted 2,124 shares, increasing direct ownership by 42,480% to 2,129 units (SEC Form 4)

Director Botha Roelof sold $17,184,092 worth of shares (78,000 units at $220.31) (SEC Form 4)

PRESIDENT, CLINICALDIAGNOSTICS Moshkevich Solomon sold $335,091 worth of shares (1,652 units at $202.84) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 140,643 units (SEC Form 4) to satisfy withholding obligation

PRESIDENT, CHIEF BUS. OFFICER Fesko John sold $291,684 worth of shares (1,438 units at $202.84) as part of a pre-agreed trading plan, decreasing direct ownership by 0.77% to 185,782 units (SEC Form 4) (withholding tax)

CO-FOUNDER Sheena Jonathan sold $959,451 worth of shares (4,650 units at $206.33) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 252,502 units (SEC Form 4)

EXECUTIVE CHAIRMAN Rabinowitz Matthew was granted 2,389 shares and sold $1,642,211 worth of shares (7,708 units at $213.05) as part of a pre-agreed trading plan, decreasing direct ownership by 0.22% to 2,377,843 units (SEC Form 4) to satisfy tax liability

CHIEF FINANCIAL OFFICER Brophy Michael Burkes sold $165,984 worth of shares (795 units at $208.79) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 57,496 units (SEC Form 4) (for withholding tax)

CEO AND PRESIDENT Chapman Steven Leonard sold $185,956 worth of shares (902 units at $206.16) as part of a pre-agreed trading plan, decreasing direct ownership by 0.60% to 149,867 units (SEC Form 4) (for withholding tax)

PRESIDENT, CHIEF BUS. OFFICER Fesko John sold $59,993 worth of shares (291 units at $206.16) as part of a pre-agreed trading plan, decreasing direct ownership by 0.16% to 187,220 units (SEC Form 4) to cover withholding tax

PRESIDENT, CLINICALDIAGNOSTICS Moshkevich Solomon sold $693,560 worth of shares (3,405 units at $203.69) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 142,295 units (SEC Form 4) (for tax liability)

CO-FOUNDER Sheena Jonathan sold $22,059 worth of shares (107 units at $206.16) as part of a pre-agreed trading plan, decreasing direct ownership by 0.04% to 255,652 units (SEC Form 4) to satisfy withholding tax

SEC. AND CHIEF LEGAL OFFICER Rabinowitz Daniel sold $68,033 worth of shares (330 units at $206.16) as part of a pre-agreed trading plan, decreasing direct ownership by 0.15% to 222,694 units (SEC Form 4) to satisfy withholding tax

CHIEF FINANCIAL OFFICER Brophy Michael Burkes sold $1,001,645 worth of shares (5,063 units at $197.84) as part of a pre-agreed trading plan, decreasing direct ownership by 8% to 58,291 units (SEC Form 4) (withholding obligation)

CEO AND PRESIDENT Chapman Steven Leonard sold $1,191,775 worth of shares (5,838 units at $204.14) as part of a pre-agreed trading plan, decreasing direct ownership by 4% to 150,769 units (SEC Form 4) to satisfy tax liability

CO-FOUNDER Sheena Jonathan sold $699,693 worth of shares (3,544 units at $197.43) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 255,711 units (SEC Form 4) (withholding obligation)

SEC. AND CHIEF LEGAL OFFICER Rabinowitz Daniel sold $379,811 worth of shares (1,861 units at $204.09) as part of a pre-agreed trading plan, decreasing direct ownership by 0.83% to 223,024 units (SEC Form 4) (tax liability)

PRESIDENT, CHIEF BUS. OFFICER Fesko John sold $344,517 worth of shares (1,688 units at $204.10) as part of a pre-agreed trading plan, decreasing direct ownership by 0.89% to 187,511 units (SEC Form 4) to cover taxes

PRESIDENT, CLINICALDIAGNOSTICS Moshkevich Solomon sold $445,341 worth of shares (2,182 units at $204.10) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 145,700 units (SEC Form 4) (withholding tax)

Director Marcus Gail Boxer was granted 330 shares, increasing direct ownership by 6% to 6,183 units (SEC Form 4)

Director Baynes Roy D. was granted 83 shares, increasing direct ownership by 0.45% to 18,512 units (SEC Form 4)

Director Bertagnolli Monica was granted 83 shares, increasing direct ownership by 2% to 5,374 units (SEC Form 4)

Director Chapman Rowan E was granted 336 shares, increasing direct ownership by 6% to 6,088 units (SEC Form 4)

Director Rosenman Herm was granted 339 shares, increasing direct ownership by 2% to 20,780 units (SEC Form 4)

Director Rubin Eric H was granted 5 shares (SEC Form 4)

Director Botha Roelof was granted 354 shares, increasing direct ownership by 14% to 2,894 units (SEC Form 4)

Director Williams Brinkley Ruth was granted 86 shares, increasing direct ownership by 2% to 5,475 units (SEC Form 4)

SEC Form 4 filed by Sheena Jonathan

SEC Form 3 filed by new insider Rubin Eric H

SEC Form 4 filed by Rabinowitz Matthew